Dexcom launches AI-powered meal logging for CGM users
July 28, 2025
Dexcom (Nadsaq:DXCM) announced today that it released a new AI-powered photo meal logging feature for its Stelo platform.
Dexcom (Nadsaq:DXCM) announced today that it released a new AI-powered photo meal logging feature for its Stelo platform.
Cardiosense announced today that it received FDA 510(k) clearance for its CardioTag wearable sensor device.
The test employs advanced RNA technology to identify biomarkers for colorectal cancer and advanced adenomas.
Designed for near-patient use, the test operates on an improved version of MeMed’s current platform.
Simplified Process Aims to Boost Participation in Colorectal Cancer Screening and Improve Early Detection Rates
Using mathematical analysis of patterns of human and animal cell behavior, scientists say they have developed a computer program that mimics the behavior of such cells in any part of the body.
Researchers from Columbia Engineering have established a framework for the design of bioactive injectable hydrogels formulated with extracellular vesicles (EVs) for tissue engineering and regenerative medicine applications.
STEWARTVILLE, Minn., July 24, 2025 /PRNewswire/ — Minnesota Medical Technologies, today announced that it received FDA 510(k) clearance for its fecal incontinence device (“StaySure(™)”).
Clinical milestone underscores BD’s growing role in self-administered drug delivery and expands real-world evaluation of its on-body injection platform for large-volume biologics.
New minimally invasive diagnostic aids in ruling out Alzheimer’s disease early, expanding access to timely and accurate neurological assessments across Europe.